BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 17924284)

  • 1. Mobilization of haematopoietic and non-haematopoietic cells by granulocyte-colony stimulating factor and vascular endothelial growth factor gene therapy in patients with stable severe coronary artery disease.
    Wang Y; Ripa RS; Jørgensen E; Hesse B; Mortensen S; Kastrup J
    Scand Cardiovasc J; 2007 Dec; 41(6):397-404. PubMed ID: 17924284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intramyocardial injection of vascular endothelial growth factor-A165 plasmid followed by granulocyte-colony stimulating factor to induce angiogenesis in patients with severe chronic ischaemic heart disease.
    Ripa RS; Wang Y; Jørgensen E; Johnsen HE; Hesse B; Kastrup J
    Eur Heart J; 2006 Aug; 27(15):1785-92. PubMed ID: 16825290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and efficacy profile of G-CSF therapy in patients with acute on chronic liver failure.
    Di Campli C; Zocco MA; Saulnier N; Grieco A; Rapaccini G; Addolorato G; Rumi C; Santoliquido A; Leone G; Gasbarrini G; Gasbarrini A
    Dig Liver Dis; 2007 Dec; 39(12):1071-6. PubMed ID: 17964871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parathyroid hormone effectively induces mobilization of progenitor cells without depletion of bone marrow.
    Brunner S; Zaruba MM; Huber B; David R; Vallaster M; Assmann G; Mueller-Hoecker J; Franz WM
    Exp Hematol; 2008 Sep; 36(9):1157-66. PubMed ID: 18504066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Feasibility and safety of G-CSF administration to induce bone marrow-derived cells mobilization in patients with end stage liver disease.
    Gaia S; Smedile A; Omedè P; Olivero A; Sanavio F; Balzola F; Ottobrelli A; Abate ML; Marzano A; Rizzetto M; Tarella C
    J Hepatol; 2006 Jul; 45(1):13-9. PubMed ID: 16635534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pegylated granulocyte colony-stimulating factor mobilizes CD34+ cells with different stem and progenitor subsets and distinct functional properties in comparison with unconjugated granulocyte colony-stimulating factor.
    Bruns I; Steidl U; Fischer JC; Czibere A; Kobbe G; Raschke S; Singh R; Fenk R; Rosskopf M; Pechtel S; von Haeseler A; Wernet P; Tenen DG; Haas R; Kronenwett R
    Haematologica; 2008 Mar; 93(3):347-55. PubMed ID: 18268278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone marrow derived mesenchymal cell mobilization by granulocyte-colony stimulating factor after acute myocardial infarction: results from the Stem Cells in Myocardial Infarction (STEMMI) trial.
    Ripa RS; Haack-Sørensen M; Wang Y; Jørgensen E; Mortensen S; Bindslev L; Friis T; Kastrup J
    Circulation; 2007 Sep; 116(11 Suppl):I24-30. PubMed ID: 17846310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. G-CSF-induced mobilization of CD34(+) progenitor cells and proarrhythmic effects in patients with severe coronary artery disease.
    Wolfram O; Jentsch-Ullrich K; Wagner A; Hammwöhner M; Steinke R; Franke A; Zupan I; Klein HU; Goette A
    Pacing Clin Electrophysiol; 2007 Jan; 30 Suppl 1():S166-9. PubMed ID: 17302697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD34+ cell adhesion molecule profiles differ between patients mobilized with granulocyte-colony-stimulating factor alone and chemotherapy followed by granulocyte-colony-stimulating factor.
    Ford CD; Greenwood J; Anderson J; Snow G; Petersen FB
    Transfusion; 2006 Feb; 46(2):193-8. PubMed ID: 16441594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intra-coronary high-dose CD34+ stem cells in patients with chronic ischemic heart disease: a 12-month follow-up.
    Boyle AJ; Whitbourn R; Schlicht S; Krum H; Kocher A; Nandurkar H; Bergmann S; Daniell M; O'Day J; Skerrett D; Haylock D; Gilbert RE; Itescu S
    Int J Cardiol; 2006 Apr; 109(1):21-7. PubMed ID: 15970342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary hyperparathyroidism is associated with increased circulating bone marrow-derived progenitor cells.
    Brunner S; Theiss HD; Murr A; Negele T; Franz WM
    Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1670-5. PubMed ID: 17911347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endogenous G-CSF and CD34+ cell mobilization after acute myocardial infarction.
    Leone AM; Rutella S; Bonanno G; Contemi AM; de Ritis DG; Giannico MB; Rebuzzi AG; Leone G; Crea F
    Int J Cardiol; 2006 Aug; 111(2):202-8. PubMed ID: 16051386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of granulocyte colony simulating factor on functional activities of endothelial progenitor cells in patients with chronic ischemic heart disease.
    Honold J; Lehmann R; Heeschen C; Walter DH; Assmus B; Sasaki K; Martin H; Haendeler J; Zeiher AM; Dimmeler S
    Arterioscler Thromb Vasc Biol; 2006 Oct; 26(10):2238-43. PubMed ID: 16902165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. G-CSF during large field radiotherapy reduces bone marrow recovery capacity.
    Pape H; Orth K; Heese A; Heyll A; Kobbe G; Schmitt G; Niederbichler AD; Peiper M; Schwarz A; Boelke E
    Eur J Med Res; 2006 Aug; 11(8):322-8. PubMed ID: 17052967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and effectiveness of granulocyte-colony stimulating factor in mobilizing stem cells and improving cytokine profile in advanced chronic heart failure.
    Joseph J; Rimawi A; Mehta P; Cottler-Fox M; Sinha A; Singh BK; Pacheco R; Smith ES; Mehta JL
    Am J Cardiol; 2006 Mar; 97(5):681-4. PubMed ID: 16490437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Granulocyte-colony stimulating factor therapy to induce neovascularization in ischemic heart disease.
    Ripa RS
    Dan Med J; 2012 Mar; 59(3):B4411. PubMed ID: 22381094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Etoposide 1.0 g/m2 or 1.5 g/m2 combined with granulocyte colony-stimulating factor for mobilization of peripheral blood stem cells in patients with malignancy: efficacy and toxicity.
    Li B; Yang JL; Shi YK; He XH; Han XH; Zhou SY; Liu P; Yang S; Zhang CG
    Cytotherapy; 2009; 11(3):362-71. PubMed ID: 19037766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD34+ and endothelial progenitor cells in patients with various degrees of congestive heart failure.
    Valgimigli M; Rigolin GM; Fucili A; Porta MD; Soukhomovskaia O; Malagutti P; Bugli AM; Bragotti LZ; Francolini G; Mauro E; Castoldi G; Ferrari R
    Circulation; 2004 Sep; 110(10):1209-12. PubMed ID: 15249502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid succession of peripheral blood progenitor cell mobilization cycles in patients with chronic heart failure: effects on the hematopoietic system.
    Hüttmann A; Gutersohn A; Noppeney R; Neumann T; Erbel R; Dührsen U
    Transfusion; 2006 Aug; 46(8):1424-31. PubMed ID: 16934081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Granulocyte colony-stimulating factor-induced blood stem cell mobilisation in patients with chronic heart failure--Feasibility, safety and effects on exercise tolerance and cardiac function.
    Hüttmann A; Dührsen U; Stypmann J; Noppeney R; Nückel H; Neumann T; Gutersohn A; Nikol S; Erbel R
    Basic Res Cardiol; 2006 Jan; 101(1):78-86. PubMed ID: 16237506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.